Shepherd Veterinary Software vs Danaher Corporation
Side-by-side comparison of AI visibility scores, market position, and capabilities
YC-backed cloud veterinary PMS designed from the ground up by veterinarians for modern clinic workflow efficiency. San Francisco CA; founded 2018;
About
Shepherd Veterinary Software is a San Francisco-based cloud veterinary practice management system backed by Y Combinator and designed from the ground up for the operational workflow needs of modern veterinary clinics. Founded in 2018 by veterinarians and technologists who experienced firsthand the frustrations of legacy practice management systems, Shepherd built a clean, intuitive platform that integrates appointment scheduling, medical records, treatment tracking, invoicing, and inventory management into a unified workflow optimized for the pace and multitasking demands of a busy veterinary practice. Unlike older systems that were designed around a desktop paradigm and adapted for web, Shepherd was built as a cloud-native application from day one.\n\nShepherd's clinical workflow design reflects its founding team's veterinary experience. The platform's whiteboard feature provides a real-time view of every patient in the clinic—which exam room they are in, what treatments have been administered, what orders are outstanding, and who is responsible for each task. This "at a glance" operational view reduces the communication overhead between veterinarians, technicians, and receptionists that leads to errors and delays in busy multi-doctor practices. The treatment sheet auto-populates charges based on administered treatments, reducing the billing leakage common in practices where staff must manually add charges from memory.\n\nShepherd targets independent veterinary practices and small veterinary groups in the United States, competing with established systems including IDEXX's AVImark, ezyVet, Cornerstone, and ImproMed in the veterinary practice management market. The company differentiates on user experience quality, cloud-native reliability, and the speed of its development cycle—as a well-funded startup with a modern tech stack, Shepherd can ship product improvements significantly faster than legacy software vendors. Shepherd has gained traction primarily through referrals within veterinary professional networks and targeted digital marketing reaching veterinary clinic owners and practice managers.
Washington DC life sciences instruments (NYSE: DHR) at $23.9B FY2024 revenue; Cytiva bioprocessing, Beckman Coulter diagnostics, biopharma destocking recovery, 2025 core revenue +3% guidance competing with Thermo Fisher.
About
Danaher Corporation is a Washington, D.C.-based global science and technology company — publicly traded on the New York Stock Exchange (NYSE: DHR) as an S&P 500 Health Care component — developing, manufacturing, and marketing analytical instruments, reagents, consumables, software, and services for life sciences research, clinical diagnostics, and environmental monitoring through approximately 65,000 employees worldwide. In fiscal year 2024, Danaher reported revenues of $23.9 billion (flat year-over-year) with non-GAAP core revenue declining 1% as the biopharma sector's inventory destocking cycle continued, with Q4 2024 revenue of $6.5 billion (+2.0% reported, +1.0% core) representing an inflection toward recovery, generating $6.7 billion in operating cash flow and $5.3 billion in free cash flow. Danaher guided 2025 core revenue growth of approximately 3% — marking the expected return to growth as biopharma customers who destocked pandemic-era bioprocessing supply surpluses return to normalized purchasing. CEO Rainer Blair leads Danaher's post-spinoff strategy: in September 2023, Danaher separated its Environmental & Applied Solutions segment as Veralto Corporation (NYSE: VLTO), creating two independent public companies — Danaher (pure-play life sciences and diagnostics) and Veralto (water quality and product identification). Danaher's current portfolio centers on bioprocessing (Cytiva's bioreactors, membranes, single-use manufacturing for drug production), clinical diagnostics (Beckman Coulter chemistry and hematology analyzers, Radiometer blood gas analyzers, Cepheid molecular diagnostics), and life sciences research instruments (SCIEX mass spectrometry, Leica Microsystems microscopy).
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.